Eli Lilly & Co. (LLY) Misses Q4 EPS by 1c, Revenue Beats, FY19 EPS Guidance Misses

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Eli Lilly & Co. (LLY) Misses Q4 EPS by 1c, Revenue Beats, FY19 EPS Guidance Misses

Eli Lilly (LLY) PT Raised to $115 at Credit Suisse

February 7, 2019 7:59 AM EST

Credit Suisse analyst Vamil Divan raised the price target on Eli Lilly (NYSE: LLY) to $115.00 (from $112.00) while maintaining a Neutral rating following the company's 4Q earnings report. Overall, 4Q18 was mixed, as revenues beat expectations but EPS missed forecasts by a... More

Eli Lilly (LLY) PT Raised to $143 at Cantor Fitzgerald

February 6, 2019 1:28 PM EST

Cantor Fitzgerald analyst Louise Chen raised the price target on Eli Lilly (NYSE: LLY) to $143.00 (from $128.00) while maintaining a Overweight rating.

Chen commented, "Post a modest 4Q18 EPS miss, we maintain our OW rating and increase our 12 month PT to $143... More